Staccato Prochlorperazine Single Dose PK Study

NCT00610727 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Prochlorperazine 0.5 mg IV over 5 sec
DRUG: Inhaled prochlorperazine 0.625 mg
DRUG: Inhaled prochlorperazine 1.25 mg
DRUG: Inhaled prochlorperazine 2.5 mg
DRUG: Inhaled prochlorperazine 5 mg
DRUG: Inhaled prochlorperazine 10 mg
DRUG: Inhaled placebo
DRUG: Prochlorperazine 10 mg IV over 5 sec

Sponsor

Nova Pneuma Inc.

Collaborators

[object Object]